Repeat <i>in situ</i> ablation vs. extensive ablation for recurrent persistent atrial fibrillation
Among patients with PerAF undergoing repeat ablation, the EXT group demonstrated superior clinical efficacy compared with the in situ group, indicating that PV reconnection and linear lesion reconduction may not constitute the predominant mechanisms driving AF recurrence. These may still contribute significantly, but targeting additional non-PV substrates further improves outcomes.
Authors
- Yu Zhang (ORCID: https://orcid.org/0000-0002-4976-9158)
- Weifeng Jiang (ORCID: https://orcid.org/0000-0002-7757-004X)
- Shaohui Wu (ORCID: https://orcid.org/0000-0002-1343-898X)
- Mu Qin (ORCID: https://orcid.org/0000-0002-1645-4758)
- Shiyi Wang (ORCID: https://orcid.org/0000-0003-3433-3025)
- Feng Zhang (ORCID: https://orcid.org/0000-0002-3998-8939)
- Xu Liu (ORCID: https://orcid.org/0000-0001-9703-5258)
- Xumin Hou (ORCID: https://orcid.org/0000-0001-7619-1534)
- Nannan Chen (ORCID: https://orcid.org/0000-0002-0152-1444)
- Ziliang Song (ORCID: https://orcid.org/0000-0002-7403-5236)
- Yang Liu (ORCID: https://orcid.org/0000-0003-1953-2093)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
- Jinshan Hospital of Fudan University (CN)
- Yangpu Hospital of Tongji University (CN)
Publication Details
- Journal
- EP Europace
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1093/europace/euaf232
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78